PTCA and CABG    Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room J Am Coll Cardiol (2009) 53; 232-41 D. X. Zhao, M. Leacche, J. M. Balaguer, K. D. Boudoulas, J. A. Damp, J. P. Greelish, J. G. Byrne, R. M. Ahmad, S. K. Ball, J. H. Cleator, R. J. Deegan, S. S. Eagle, P. P. Fong, J. L. Fredi, S. J. Hoff, H. S. Jennings, 3rd, J. A. McPherson, R. N. Piana, M. Pretorius, M. A. Robbins, D. A. Slosky and A. Thompson The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy J Am Coll Cardiol (2008) 52; 620-5 C. C. Wee, S. Girotra, A. R. Weinstein, M. A. Mittleman and K. J. Mukamal Impact on contrast, fluoroscopy, and catheter utilization from knowing the coronary artery bypass graft anatomy before diagnostic coronary angiography I. Varghese, Am J Cardiol (2008) 101; 1729-32 D. M. Boatman, C. T. Peters, J. Daye, A. Haider, M. Roesle, S. Banerjee and E. S. Brilakis Three life-years gained from smoking cessation after coronary artery bypass surgery: a 30-year follow-up study Am Heart J (2008) 156; 473-6 R. T. van Domburg, W. S. op Reimer, S. E. Hoeks, A. P. Kappetein and A. J. Bogers Impact of early and delayed stroke on in-hospital and long-term mortality after isolated coronary artery bypass grafting Am J Cardiol (2008) 102; 411-7 I. K. Toumpoulis, C. E. Anagnostopoulos, T. P. Chamogeorgakis, D. C. Angouras, M. A. Kariou, D. G. Swistel and C. K. Rokkas Stents versus bypass grafting for left main coronary artery disease N Engl J Med (2008) 359; 423-4; author reply 25 H. Tomoda Stents versus bypass grafting for left main coronary artery disease N Engl J Med (2008) 359; 424; author reply 25 J. A. Tayek Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease Am J Cardiol (2008) 101; 1259-62 H. Takagi, N. Kawai and T. Umemoto PCI or CABG in coronary artery disease? Lancet (2009) 373; 1150-2 D. P. Taggart The impact of diabetic status on coronary artery bypass graft patency: insights from the radial artery patency study Circulation (2008) 118; S222-5 S. K. Singh, N. D. Desai, S. D. Petroff, S. Deb, E. A. Cohen, S. Radhakrishnan, L. Schwartz, J. Dubbin and S. E. Fremes Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery Circulation (2008) 117; 356-62 M. Singh, B. J. Gersh, S. Li, J. S. Rumsfeld, J. A. Spertus, S. M. O'Brien, R. M. Suri and E. D. Peterson Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery J Am Coll Cardiol (2008) 51; 1938-43 S. J. Shah, D. D. Waters, P. Barter, J. J. Kastelein, J. Shepherd, N. K. Wenger, D. A. DeMicco, A. Breazna and J. C. LaRosa Stents versus coronary-artery bypass grafting for left main coronary artery disease N Engl J Med (2008) 358; 1781-92 K. B. Seung, D. W. Park, Y. H. Kim, S. W. Lee, C. W. Lee, M. K. Hong, S. W. Park, S. C. Yun, H. C. Gwon, M. H. Jeong, Y. Jang, H. S. Kim, P. J. Kim, I. W. Seong, H. S. Park, T. Ahn, I. H. Chae, S. J. Tahk, W. S. Chung and S. J. Park Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med (2009) 360; 961-72 P. W. Serruys, M. C. Morice, A. P. Kappetein, A. Colombo, D. R. Holmes, M. J. Mack, E. Stahle, T. E. Feldman, M. van den Brand, E. J. Bass, N. Van Dyck, K. Leadley, K. D. Dawkins and F. W. Mohr Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D) Am J Cardiol (2009) 103; 632-8 L. Schwartz, K. E. Kip, E. Alderman, J. Lu, E. R. Bates, V. Srinivas, R. G. Bach, L. D. Mighton, F. Feit, S. King, 3rd and R. L. Frye Does location of the second internal thoracic artery graft influence outcome of coronary artery bypass grafting? Circulation (2008) 118; S210-5 J. F. Sabik, 3rd, A. Stockins, E. R. Nowicki, E. H. Blackstone, P. L. Houghtaling, B. W. Lytle and F. D. Loop Requirement for emergent coronary artery bypass surgery following percutaneous coronary intervention in the stent era Am J Cardiol (2009) 103; 950-3 P. Roy, A. de Labriolle, N. Hanna, L. Bonello, T. Okabe, T. L. Pinto Slottow, D. H. Steinberg, R. Torguson, K. Kaneshige, Z. Xue, L. F. Satler, K. M. Kent, W. O. Suddath, A. D. Pichard, J. Lindsay and R. Waksman Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery Circulation (2008) 117; 24-31 J. L. Rouleau, W. J. Warnica, R. Baillot, P. J. Block, S. Chocron, D. Johnstone, M. G. Myers, C. D. Calciu, S. Dalle-Ave, P. Martineau, C. Mormont and W. H. van Gilst Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians Circulation (2008) 118; 2374-81 J. Rodes-Cabau, J. Deblois, O. F. Bertrand, S. Mohammadi, J. Courtis, E. Larose, F. Dagenais, J. P. Dery, P. Mathieu, M. Rousseau, G. Barbeau, R. Baillot, O. Gleeton, J. Perron, C. M. Nguyen, L. Roy, D. Doyle, R. De Larochelliere, P. Bogaty and P. Voisine Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes Am Heart J (2008) 155; 661-7 B. Reicher, R. S. Poston, M. R. Mehra, A. Joshi, P. Odonkor, Z. Kon, P. A. Reyes and D. A. Zimrin Endovascular carotid artery stenting and early coronary artery bypass grafting for asymptomatic carotid artery stenosis: long-term outcomes and neurologic events Catheter Cardiovasc Interv (2009) 73; 139-42 P. S. Ranaweera, B. C. Bigelow, M. C. Leary, R. de la Torre, F. Sellke and L. A. Garcia Stents versus bypass grafting for left main coronary artery disease N Engl J Med (2008) 359; 423; author reply 25 M. Pocar, F. Donatelli and A. Moneta Effects of off-pump versus on-pump coronary artery bypass grafting on early and late right ventricular function Circulation (2008) 117; 2202-10 T. J. Pegg, J. B. Selvanayagam, T. D. Karamitsos, R. J. Arnold, J. M. Francis, S. Neubauer and D. P. Taggart A randomized trial of on-pump beating heart and conventional cardioplegic arrest in coronary artery bypass surgery patients with impaired left ventricular function using cardiac magnetic resonance imaging and biochemical markers Circulation (2008) 118; 2130-8 T. J. Pegg, J. B. Selvanayagam, J. M. Francis, T. D. Karamitsos, Z. Maunsell, L. M. Yu, S. Neubauer and D. P. Taggart Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease Circulation (2008) 117; 2079-86 D. W. Park, S. C. Yun, S. W. Lee, Y. H. Kim, C. W. Lee, M. K. Hong, J. J. Kim, S. J. Choo, H. Song, C. H. Chung, J. W. Lee, S. W. Park and S. J. Park Appropriateness of coronary artery bypass graft surgery performed in northern New England J Am Coll Cardiol (2008) 51; 2323-8 G. T. O'Connor, E. M. Olmstead, W. C. Nugent, B. J. Leavitt, R. A. Clough, P. W. Weldner, D. C. Charlesworth, K. Chaisson, D. Sisto, E. R. Nowicki, R. P. Cochran and D. J. Malenka Evolution of surgical treatment of coronary artery occlusive disease JAMA (2009) 301; 970-1 G. P. Noon Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2643; author reply 43-4 A. C. Ng and L. Kritharides Assessment of patients after coronary artery bypass grafting using 64-slice computed tomography Am J Cardiol (2009) 103; 667-73 I. Nazeri, P. Shahabi, M. Tehrai, B. Sharif-Kashani and A. Nazeri Hematologic parameters, atherosclerotic progression, and prognosis in patients with previous coronary artery bypass grafting (from the Post CABG Trial) Am J Cardiol (2009) 103; 328-32 K. J. Mukamal, G. A. Wellenius and M. A. Mittleman Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate J Am Coll Cardiol (2008) 52; 582-4; author reply 84-6 E. Meliga, M. Valgimigli, P. Buszman and P. W. Serruys Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardiac Database Circulation (2008) 117; 876-85 R. H. Mehta, J. D. Grab, S. M. O'Brien, D. D. Glower, C. K. Haan, J. S. Gammie and E. D. Peterson Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study Circulation (2008) 117; 1216-27 H. C. McGill, Jr., C. A. McMahan and S. S. Gidding In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction Eur Heart J (2008) 29; 2201 M. R. Makowski, U. Ebersberger, S. Nekolla and M. Schwaiger Diagnostic-therapeutic cascade revisited: coronary angiography, coronary artery bypass graft surgery, and percutaneous coronary intervention in the modern era Circulation (2008) 118; 2797-802 F. L. Lucas, A. E. Siewers, D. J. Malenka and D. E. Wennberg Off-pump coronary artery bypass graft surgery in California, 2003 to 2005 Am Heart J (2008) 156; 1095-102 Z. Li, K. K. Yeo, J. P. Parker, G. Mahendra, J. N. Young and E. A. Amsterdam Comparison of Drug-Eluting Stents and Coronary Artery Bypass Surgery for the Treatment of Multivessel Coronary Disease. Three-Year Follow-Up Results From a Single Institution Circulation (2009) Y. Li, Z. Zheng, B. Xu, S. Zhang, W. Li, R. Gao and S. Hu Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease Catheter Cardiovasc Interv (2009) 73; 612-7 G. Lemesle, L. Bonello, A. de Labriolle, D. H. Steinberg, P. Roy, T. L. Pinto Slottow, R. Torguson, K. Kaneshige, Z. Xue, W. O. Suddath, L. F. Satler, K. M. Kent, J. Lindsay, A. D. Pichard and R. Waksman CABG vs. stenting--clinical implications of the SYNTAX trial N Engl J Med (2009) 360; e10 T. H. Lee, L. D. Hillis and E. G. Nabel Coronary revascularization in context N Engl J Med (2009) 360; 1024-6 R. A. Lange and L. D. Hillis Impact of statin use on outcomes after coronary artery bypass graft surgery Circulation (2008) 118; 1785-92 A. Kulik, M. A. Brookhart, R. Levin, M. Ruel, D. H. Solomon and N. K. Choudhry Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II) Heart (2009) N. Kukreja, P. W. Serruys, B. de Bruyne, A. Colombo, C. Macaya, G. Richardt, J. Fajadet, C. Hamm, D. Goedhart, N. Macours and H. P. Stoll Association of previous coronary artery bypass graft surgery with door-to-balloon time and in-hospital outcomes: a report from the National Cardiovascular Data Registry (NCDR) J Am Coll Cardiol (2008) 52; 1665-70 M. S. Kim, T. Y. Wang, D. Dai, A. J. Klein, E. D. Peterson, J. S. Rumsfeld and J. C. Messenger Clopidogrel use and bleeding after coronary artery bypass graft surgery Am Heart J (2008) 156; 886-92 J. H. Kim, L. K. Newby, R. M. Clare, L. K. Shaw, A. J. Lodge, P. K. Smith, E. M. Jolicoeur, S. V. Rao, R. C. Becker, D. B. Mark and C. B. Granger Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial J Am Coll Cardiol (2008) 51; 2011-6 H. Kelbaek, L. Klovgaard, S. Helqvist, J. F. Lassen, L. R. Krusell, T. Engstrom, H. E. Botker, E. Jorgensen, K. Saunamaki, S. Aljabbari, P. Thayssen, A. Galloe, G. V. Jensen and L. Thuesen Percutaneous intervention vs. coronary-artery bypass grafting in left main coronary disease N Engl J Med (2008) 358; 1851-3 R. H. Jones Percutaneous coronary intervention versus coronary artery bypass grafting as primary revascularization in patients with acute coronary syndrome Am J Cardiol (2008) 102; 173-9 W. Hochholzer, H. J. Buettner, D. Trenk, T. Breidthardt, M. Noveanu, K. Laule, M. Christ, C. Schindler, F. J. Neumann and C. Mueller Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials Lancet (2009) 373; 1190-7 M. A. Hlatky, D. B. Boothroyd, D. M. Bravata, E. Boersma, J. Booth, M. M. Brooks, D. Carrie, T. C. Clayton, N. Danchin, M. Flather, C. W. Hamm, W. A. Hueb, J. Kahler, S. F. Kelsey, S. B. King, A. S. Kosinski, N. Lopes, K. M. McDonald, A. Rodriguez, P. Serruys, U. Sigwart, R. H. Stables, D. K. Owens and S. J. Pocock Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2642-3; author reply 43-4 K. J. Harjai Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease N Engl J Med (2008) 358; 331-41 E. L. Hannan, C. Wu, G. Walford, A. T. Culliford, J. P. Gold, C. R. Smith, R. S. Higgins, R. E. Carlson and R. H. Jones Relationship between preventability of death after coronary artery bypass graft surgery and all-cause risk-adjusted mortality rates Circulation (2008) 117; 2969-76 V. Guru, J. V. Tu, E. Etchells, G. M. Anderson, C. D. Naylor, R. J. Novick, C. M. Feindel, F. D. Rubens, K. Teoh, A. Mathur, A. Hamilton, D. Bonneau, C. Cutrara, P. C. Austin and S. E. Fremes Drug-eluting compared with bare-metal coronary stents among elderly patients J Am Coll Cardiol (2008) 51; 2017-24 P. W. Groeneveld, M. A. Matta, A. P. Greenhut and F. Yang 10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial J Am Coll Cardiol (2008) 52; 815-7 J. J. Goy, U. Kaufmann, M. Hurni, S. Cook, F. Versaci, P. Ruchat, O. Bertel, M. Pieper, B. Meier, L. Chiarello and E. Eeckhout Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial Am Heart J (2008) 155; 215-23 M. E. Farkouh, G. Dangas, M. B. Leon, C. Smith, R. Nesto, J. B. Buse, D. J. Cohen, E. Mahoney, L. Sleeper, S. King, 3rd, M. Domanski, S. McKinlay and V. Fuster Results of percutaneous coronary intervention of the unprotected left main coronary artery in 143 patients and comparison of 30-day mortality to results of coronary artery bypass grafting Am J Cardiol (2008) 101; 75-81 C. Dubois, J. Dens, P. Sinnaeve, A. Belmans, J. Van Cleemput, M. Mendez, J. Piessens and W. Desmet Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2641-2; author reply 43-4 J. Daemen, N. Kukreja and P. W. Serruys Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials Circulation (2008) 118; 1146-54 J. Daemen, E. Boersma, M. Flather, J. Booth, R. Stables, A. Rodriguez, G. Rodriguez-Granillo, W. A. Hueb, P. A. Lemos and P. W. Serruys Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict Am Heart J (2008) 155; 841-7 D. P. Chew, K. W. Mahaffey, H. D. White, Z. Huang, J. W. Hoekstra, J. J. Ferguson, R. M. Califf and P. E. Aylward Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy Am Heart J (2008) 155; 239-44 D. P. Chew, Z. Huang, K. S. Pieper, H. White, K. W. Mahaffey, J. J. Ferguson, R. M. Califf and P. G. Aylward Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2643; author reply 43-4 J. H. Burack Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials) Am J Cardiol (2008) 102; 552-8 E. S. Brilakis, J. A. de Lemos, C. P. Cannon, S. D. Wiviott, S. A. Murphy, D. A. Morrow, M. S. Sabatine, S. Banerjee, M. A. Blazing, R. M. Califf and E. Braunwald Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients Am J Cardiol (2008) 101; 169-72 s. J. Brener, J. M. Galla, R. Bryant, 3rd, J. F. Sabik, 3rd and S. G. Ellis Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS) J Circulation (2008) 118; 381-8 . Booth, T. Clayton, J. Pepper, F. Nugara, M. Flather, U. Sigwart and R. H. Stables Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004 Heart (2009) 95; 304-11 H. M. Blackledge and I. B. Squire Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis J Am Coll Cardiol (2008) 52; 1693-701 J. S. Berger, C. B. Frye, Q. Harshaw, F. H. Edwards, S. R. Steinhubl and R. C. Becker Stents versus bypass grafting for left main coronary artery disease N Engl J Med (2008) 359; 424-5; author reply 25 J. R. Arnold and A. P. Banning Hemodynamic evaluation of coronary artery bypass graft lesions using fractional flow reserve Catheter Cardiovasc Interv (2008) 72; 479-85 R. Aqel, G. J. Zoghbi, F. Hage, L. Dell'Italia and A. E. Iskandrian Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study J Am Coll Cardiol (2009) 53; 1194-201 H. Abdel-Aty, M. Cocker, C. Meek, J. V. Tyberg and M. G. Friedrich Drug-eluting stents vs. coronary-artery bypass grafting N Engl J Med (2008) 358; 2642; author reply 43-4 A. Abbate and M. J. Lipinski